Editor’s Commentary: There’s a very good chance that if you’re reading this article, you’re either already convinced the Covid-19 “vaccines” pose serious health threats that increase the more people get jabbed, or you’ve been sent this article by someone who cares enough about you to want you to hear the truth. We’re only getting these truths in occasional bits and pieces from corporate media and an increasing number of brave healthcare professionals who are finally obeying their conscience.
You won’t hear the truth from Big Pharma or their many pawns in government.
For two years we’ve heard from “fringe” scientists (many of whom were highly respected in their fields before they uttered a sour word about the vaccines) and alternative media screaming as loudly as possible about inefficacy and health risks associated with the jabs. Unfortunately, the vast majority of Americans didn’t listen or weren’t getting their news from the right sources. But there’s still a valid reason to press this issue since it appears the more people get jabbed, the more likely they are to experience long-term or even deadly adverse reactions.
In recent months, we’ve seen study after study from respected teams across the globe declaring the jabs are harming and oftentimes killing people. These stories are usually ignored by corporate media, but some of the most popular studies get “fact checked” by unqualified people to “debunk” the work of extremely qualified people.
How many studies will it take to convince “normies” that they need to stop getting jabbed? Hopefully, it’ll only take one massively important study that isn’t getting the attention it deserves. Dr. Joseph Mercola wrote about it in the article below, but before you read that there are two important things to understand.
First, the attitude being adopted by many who haven’t been jabbed is that the “vaccinated” are lost souls, that it’s too late for them. This is also scientifically inaccurate because stopping people from getting boosters seems to reduce the impact. Therefore, it behooves us to continue to passionately educate those we can touch. If you talk to five people about it but only one decides to stop getting boosted, it’s worthwhile.
Second, there have been more indications that “vaxx-shedding” is happening. It’s in our own best interests to slow or stop the spread of boosters. Otherwise, those around us might pollute the blood of the unvaccinated who are around them regularly.
The article below by Dr. Mercola highlights what I believe to be the most convincing study as it pertains to myocarditis. We need to start there rather than bombarding friends and family with every fear-inducing adverse reaction because myocarditis is an easier way to keep their attention. They haven’t been swayed by reports of unprecedented deaths. They weren’t swayed by famous people developing facial ticks. Therefore, getting the word out about myocarditis has the advantage of prolonged attention. Those who may have tuned you out the first time you told them millions worldwide are dying from the jabs may listen more carefully if you’re talking to them about myocarditis studies. Here’s Dr. Mercola…
Another Study Confirms Myocarditis Post Jab
STORY AT-A-GLANCE
- A study estimated the incidence of myocarditis after COVID-19 shots and compared it with expected rates in British Columbia; a significantly increased risk of myocarditis was found following COVID-19 jabs
- While seven myocarditis cases would be expected within seven days, the study found 99 cases among those who’d received the shots
- Within 21 days post-vaccination, 141 cases of myocarditis occurred. The expected rate was 20
- This worked out to a myocarditis rate of 1.37 per 100,000 COVID-19 doses, compared with an expected rate of 0.39 per 100,000 people who did not get the shots
- Rates of myocarditis after COVID-19 shots were highest among males, those aged 18 to 29 years, people who received a Moderna COVID-19 shot and people who received two doses
- The rate of myocarditis among males aged 18 to 29 who received Moderna’s COVID-19 shot was 22.9 per 100,000
Yet another study has revealed people who receive a COVID-19 shot are at an increased risk of myocarditis, or inflammation of the heart muscle.1 With symptoms similar to a heart attack, including chest pain, shortness of breath, abnormal heartbeat and fatigue,2 myocarditis isn’t something that young, healthy adults typically experience.
But soon after mRNA shots for SARS-CoV-2 became widespread, reports of myocarditis, including sudden death, began to emerge.3 In Canada, more than 32 million people had received COVID-19 shots as of September 2022.4
“Prelicensure study data did not suggest any risk of postvaccination myocarditis,” researchers with the British Columbia Centre for Disease Control wrote in the Canadian Medical Association Journal (CMAJ). However:5
“[P]ostmarketing studies have suggested an association between mRNA SARS-CoV-2 vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) and myocarditis, among other adverse events after immunization, which has raised concern regarding the safety of mRNA vaccines, specifically among younger populations.”
This prompted the featured study, which estimated the incidence of myocarditis after COVID-19 shots and compared it with expected rates in British Columbia. A significant increased risk of myocarditis was found following COVID-19 shots.
Getting a COVID-19 Shot Increases Risk of Myocarditis
The study used data from the BC COVID-19 Cohort study, which included more than 10.2 million doses of mRNA COVID-19 shots given to people 12 and over. Cases of myocarditis that occurred seven to 21 days after the shots and required hospitalization were examined. While seven myocarditis cases would be expected within seven days, the study found 99 cases among those who’d received the shots.
Within 21 days post-vaccination, 141 cases of myocarditis occurred. The expected rate was 20. This worked out to a myocarditis rate of 1.37 per 100,000 COVID-19 doses, compared with an expected rate of 0.39 per 100,000 people who did not get the shots.6 Rates of myocarditis after COVID-19 shots were highest among:7
- Males
- Those aged 18 to 29 years
- People who received a Moderna COVID-19 shot
- People who received two doses
The rate of myocarditis among males aged 18 to 29 who received Moderna’s COVID-19 shot was 22.9 per 100,000.8 The researchers concluded:9
“In this study, we found higher observed rates of myocarditis after receipt of mRNA vaccines than expected … We observed a higher rate of myocarditis among males aged 18-29 years after receipt of the second dose of mRNA-1273 (Moderna) vaccine compared with those who received BNT162b2 (Pfizer-BioNTech) …
Comparisons of observed with expected rates also confirmed these findings, with the highest observed-to-expected ratios among males 18–29 years of age after the second dose of the mRNA-1273 vaccine.”
Myocarditis Link to COVID-19 Jabs Confirmed Again and Again
Many case reports exist of myocarditis following COVID-19 jabs, but they’re still recommended as safe and effective in the U.S. The Journal of Cardiology Cases described the case of a 23-year-old man who was otherwise healthy, who experienced chest pain for three days after receiving the second dose of Pfizer’s COVID-19 shot.
Myocarditis was confirmed via MRI and other medical tests, and he was diagnosed with “acute myocarditis after COVID-19 vaccination.”10 In another example, researchers reviewed nine case series and 15 case reports involving 74 patients of myocarditis after mRNA COVID-19 shots. Again, most of the patients (94.6%) were male and young, with a median age of 17.6 years.11
In a September-October 2021 case report with literature review, it was concluded that “the outcomes of this case scenario confirm myocarditis as a probable complication of COVID-19 vaccines.”12 Another study from Israel detailed myocarditis following Pfizer’s COVID-19 jab in six male patients with a median age of 23 years.13
A similar study published in Pediatrics reported seven cases of acute myocarditis or myopericarditis in otherwise healthy adolescent males. Each had experienced chest pain within four days of receiving the second dose of Pfizer’s COVID-19 jab.14
Data published in JAMA Cardiology by physicians from the Navy, Army and Air Force also revealed a higher-than-expected rate of myocarditis in U.S. military personnel who received a COVID-19 jab.15
And a real-world case-control study from Israel16 revealed that the Pfizer COVID-19 jab is associated with a threefold increased risk of myocarditis,17 leading to the condition at a rate of 1 to 5 events per 100,000 persons.18 Other elevated risks were also identified following the COVID jab, including lymphadenopathy (swollen lymph nodes), appendicitis and herpes zoster infection.19
CDC, FDA Acknowledge Myocarditis Risk
The U.S. Centers for Disease Control and Prevention (CDC) acknowledges that COVID-19 shots are associated with an increased myocarditis risk, stating:20
“In April 2021, increased cases of myocarditis and pericarditis were reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). Data from multiple studies show a rare risk for myocarditis and/or pericarditis following receipt of mRNA COVID-19 vaccines.
These rare cases of myocarditis or pericarditis have occurred most frequently in adolescent and young adult males, ages 16 years and older, within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna).”
The CDC is now investigating long-term effects of myocarditis after COVID-19 shots and is contacting people who have experienced chest pain, shortness of breath and feelings of having a fast-beating, fluttering or pounding heart following a COVID-19 shot. In order to meet the CDC’s case definition of myocarditis following a COVID-19 shot, you must also have “medical tests to support the diagnosis of myocarditis and rule out other causes.”21
However, despite the risk, the CDC is still advising children aged 12 and older to get the jab, and the U.S. Food and Drug Administration granted full approval August 23, 2021, to Pfizer’s COVID-19 mRNA injection, now sold under the brand name Comirnaty, for people aged 16 and older.22
FDA does list myocarditis on the prescribing information for COVID-19 shots,23 and in its approval letter for Comirnaty, the FDA ordered Pfizer to conduct research to investigate the risk of inflammation in and around the heart, as voluntary reporting mechanisms are insufficient.24
The FDA accepted Pfizer’s suggested timetable for the post-approval study to evaluate incidence of heart and heart sack inflammation, which includes the submission of an interim report at the end of October 2023, a study completion date of June 30, 2025, and submission of a final report October 31, 2025.
British Health Agency Advises Against COVID-19 Jabs for Kids
Britain’s Joint Committee on Vaccination and Immunization (JCVI) recommended against COVID-9 injections for healthy 12- to 15-year-olds. JCVI member Adam Finn told Reuters:25
“… the number of serious cases that we see of COVID in children this age are really very small. There are uncertainties about the long-term implications of (myocarditis), and that makes the risk-benefit balance for these children really quite tight and much tighter than we would be comfortable to make the recommendation.”
In contrast, the CDC has downplayed the risks, stating that most people should still get jabbed: “The Advisory Committee on Immunization Practices (ACIP) and CDC have determined that the benefits (such as prevention of COVID-19 cases and its severe outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines.”26
Others, however, aren’t so sure. Cardiologist Dr. Aseem Malhotra has spoken openly about the shots’ downfalls. He said in “Safe and Effective: A Second Opinion,” a documentary by Oracle Films:27
“Having been double jabbed and being one of the first to take the Pfizer vaccine, I have — after several months critically appraising the data, speaking to eminent scientists in Oxford, Stanford and Harvard, speaking to two investigative medical journalists and being contacted by two Pfizer whistleblowers — reluctantly concluded that this vaccine is not completely safe and has unprecedented harms, which leads me to conclude that it needs to be suspended until all the raw data has been released for independent analysis.”
Deaths and Disabilities Ignored, Silenced
Myocarditis reduces your heart’s ability to pump and can cause rapid or abnormal heart rhythms that can be deadly. In severe cases, myocarditis can cause permanent damage to the heart muscle and lead to heart failure, heart attack, stroke and sudden cardiac death.28 Tragic stories have accumulated worldwide:
- In August 2021, New Zealand reported the death of a woman following Pfizer’s COVID-19 jab, which they believe was due to vaccine-induced myocarditis.29
- A previously healthy 36-year-old mother of two died 11 days after receiving a Pfizer COVID-19 shot; her death was deemed to be caused by myocarditis due to the shot.30
- Dr. Neil Singh Dhalla, a CEO of a major health clinic, fell asleep four days after he got a COVID-19 booster shot — and died from a heart attack.31 The autopsy stated myocarditis. He was only 48 years old and had never had heart problems in his life.
- In another example, epidemiologists confirmed that two teenage boys from different U.S. states died of myocarditis days after getting the Pfizer shot.32 Both had received second doses of the shot. In a study that examined the autopsy findings, it’s reported that the “myocarditis” described in the boys’ deaths is “not typical myocarditis pathology.”33
If you’re wondering why you haven’t heard more about these and other cases, it’s because Big Tech has tried to censor these stories and keep them from getting out. But the truth has a way of finding the light.
A U.S. judge ruled that the White House must release correspondence regarding a “massive censorship enterprise” with Big Tech; it’s alleged that federal agencies communicated with social media companies to suppress private speech during the pandemic.34,35
Open debate and access to data from all sources is crucial to proper informed consent, including learning why some experts believe myocarditis due to COVID-19 shots “will kill kids,” without a doubt.36
- 1, 4, 5 CMAJ November 21, 2022, 194 (45) E1529-E1536; DOI: 10.1503/cmaj.220676
- 2, 28 Mayo Clinic, Myocarditis
- 3 Rumble, Safe and Effective: A Second Opinion September 28, 2022, 37:18
- 6 University of Maryland, Center for Infectious Disease Research and Policy November 2022
- 7, 8 EurekAlert November 21, 2022
- 9 CMAJ November 21, 2022, 194 (45) E1529-E1536; DOI: 10.1503/cmaj.220676, Conclusion
- 10 Journal of Cardiology Cases May 2022, Volume 25, Issue 5, Pages 285-288
- 11 Journal of Medial Virology December 4, 2021
- 12 Diabetes Metab Syndr. 2021 September-October; 15(5): 102205
- 13 Vaccine. 2021 Jun 29;39(29):3790-3793. DOI: 10.1016/j.vaccine.2021.05.087. Epub 2021 May 28
- 14 Pediatrics. 2021 Sep;148(3):e2021052478. DOI: 10.1542/peds.2021-052478. Epub 2021 Jun 4
- 15 JAMA Cardiology, 2021; DOI: 10.1001/jamacardio.2021.2833
- 16, 18, 19 The New England Journal of Medicine August 25, 2021
- 17 MedPage Today August 25, 2021
- 20, 26 U.S. CDC, COVID-19 Vaccination, Myocarditis and Pericarditis Considerations
- 21 U.S. CDC, Investigating Long-Term Effects of Myocarditis September 23, 2022
- 22, 24 FDA.gov BLA Approval Pfizer/BioNTech August 23, 2021
- 23 STAT News August 23, 2021
- 25 Reuters September 3, 2021
- 27 Rumble, Safe and Effective: A Second Opinion September 28, 2022, 1:51
- 29 New Zealand Ministry of Health August 30, 2021
- 30 Independent May 6, 2022
- 31 BitChute December 28, 2021
- 32 Odysee February 17, 2022
- 33 Archives of Pathology & Laboratory Medicine February 2022
- 34 Rumble, Safe and Effective: A Second Opinion September 28, 2022, 52:38
- 35 Children’s Health Defense September 7, 2022
- 36 Bitchute December 11, 2021 Dr. Peter McCullough, COVID: A Legal Perspective, 27:00
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.
The answer is NO stories will convince COVidiots the jab is dangerous because they don’t take it because it’s good; they take it because they are bewitched, spiritually deluded.
there are non so blind as he who will NOT see
no amount of scientific evidence will convince them. For them it is a religious-like belief in the clot shots to ward off evil spirits of covid – the Branch Covidians. They are the people who rushed to get the shots in fear and blind faith in “experts” and “the government”.
By all means convince them to take the jab and the never ending boosters. Good way to rid the country of stupid, devoid of common sense likely Democrat voters.